Prophylactic cyclo‐oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta‐analysis

Overview of attention for article published in Cochrane database of systematic reviews, January 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 12,051 followers.

@IvanD_Florez @AGREEScientific Thanks a lot Ivan! I am developing a CPG with @methodsnerd & @JonDorling18 based on an NMA on prophylactic COX-I inhibitors in preterms currently being developed on @CochraneNeonate (link below) Will definitely check this

Reply Repost Favourite

RT @souvik_neo: Our @CochraneNeonate protocol on NMA of prophylactic COX-inhibitors is out. Main objective: To consolidate evidence on all…

Reply Repost Favourite

RT @souvik_neo: Our @CochraneNeonate protocol on NMA of prophylactic COX-inhibitors is out. Main objective: To consolidate evidence on all…

Reply Repost Favourite

RT @souvik_neo: Our @CochraneNeonate protocol on NMA of prophylactic COX-inhibitors is out. Main objective: To consolidate evidence on all…

Reply Repost Favourite

RT @souvik_neo: Our @CochraneNeonate protocol on NMA of prophylactic COX-inhibitors is out. Main objective: To consolidate evidence on all…

Reply Repost Favourite

RT @souvik_neo: Our @CochraneNeonate protocol on NMA of prophylactic COX-inhibitors is out. Main objective: To consolidate evidence on all…

Reply Repost Favourite

Our @CochraneNeonate protocol on NMA of prophylactic COX-inhibitors is out. Main objective: To consolidate evidence on all available prophylactic COX-Is in preterms using #GRADE for NMA @halifaxtim @methodsnerd @JonDorling18 @EBNEO @CochraneCanada https:

Reply Repost Favourite